FDA “stands firm” in monitoring CBD marketplace with recent warning letter

Protecting and promoting public health remains a top priority, says FDA Commissioner

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

07 Sep 2020 --- In order to allow hemp and hemp-derived cannabidiol (CBD) to be legally marketed in dietary supplements, US bipartisan legislation has been put forward by Congress... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

22 Jul 2020 --- The US Food and Drug Administration (FDA) does not intend to object to the use of certain qualified health claims regarding consuming cranberry products and a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

16 Apr 2020 --- Canadian Brewing company Molson Coors Beverage Company and Canada-based cannabis player HEXO Corp have formed a joint venture (JV) to explore opportunities for... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

12 Feb 2020 --- Despite a hazy regulatory landscape, the cannabidiol (CBD) space continues to gather pace in terms of NPD and R&D. Now US President Donald Trump has requested... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

02 Jan 2020 --- In response to industry confusion, the US Food and Drug Administration (FDA) has issued final guidance on the requirements for dual-column labeling and serving... Read More

trans